US Stock MarketDetailed Quotes

SWTX SpringWorks Therapeutics

Watchlist

54.140
+0.110+0.20%

Close Feb 26 16:00 ET

55.000
+0.860+1.59%

Pre 05:04 ET

4.06BMarket Cap-15.56P/E (TTM)

SpringWorks Therapeutics Stock Forum

Teddy123

Feb 20 05:32

SpringWorks Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Highlights Recent Business Updates

$SpringWorks Therapeutics (SWTX.US)$
Can SpringWorks' Dual Drug Strategy Transform Its Financial Future? Q4 Results Reveal Key Insights

Teddy123

Feb 12 04:44

UPDATE: SpringWorks Therapeutics Announces FDA Approval of GOMEKLI™ (mirdametinib) for the Treatment of Adult and Pediatric Patients with NF1-PN

$SpringWorks Therapeutics (SWTX.US)$
Historic FDA Approval: Groundbreaking NF1-PN Treatment Shows Remarkable 52% Response in Children

Teddy123

Feb 11 17:56

SpringWorks Therapeutics Announces FDA Approval of GOMEKLI™ (mirdametinib) for the Treatment of Adult and Pediatric Patients with NF1-PN

$SpringWorks Therapeutics (SWTX.US)$
Breakthrough FDA Approval: New Drug Shows Remarkable 52% Response Rate in Children with Rare Tumor Disease

Trytosaveabit

Feb 11 14:46

News

$SpringWorks Therapeutics (SWTX.US)$ Reuters· 2 mins ago
FDA: Approved Mirdametinib, for Adult & Pediatric Patients 2 Years of Age & Older With Nf1 Who Have Symptomatic Pn Not Amenable to Complete Resection

Kishen bossku

Feb 10 12:30

$SpringWorks Therapeutics (SWTX.US)$ wonderful 😊

Brianjh

Oct 17, 2024 09:21

Druckenmiller Stock Portfolio

Stanley Druckenmiller says he's ‘licking my wounds’ from selling Nvidia too soon
-Billionaire investor Stanley Druckenmiller told Bloomberg on Wednesday that selling all his Nvidia stock this year was a “big mistake.”
-Nvidia was Druckenmiller's top holding a year ago, but he sold it after the stock tripled in 2023.
-The shares are up another 174% this year, and Druckenmiller has missed much of the continuing rally.
Stanley Druckenmiller is an American billionair...